Shares of Klarna (KLAR) have gained 8.4% over the past four weeks to close the last trading session at $30.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $46.06 indicates a potential upside of 51.1%.The mean estimate comprises 16 short-term price targets with a standard deviation of $3.7. While the lowest estimate of $39.00 indicates a 28% increase from the current price le ...

Nuvation Bio Inc. (NUVB) closed the last trading session at $8.99, gaining 28.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.25 indicates a 25.1% upside potential.The average comprises eight short-term price targets ranging from a low of $8.00 to a high of $18.00, with a standard deviation of $2.96. While the lowest estimate indicates a decline of 11% from the current price ...

WisdomTree, Inc. (WT) closed the last trading session at $11.8, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $15.13 indicates a 28.2% upside potential.The mean estimate comprises six short-term price targets with a standard deviation of $1.5. While the lowest estimate of $13.25 indicates a 12.3% increase from the current price level, the most optimistic analyst expe ...

Shares of Photronics (PLAB) have gained 60.2% over the past four weeks to close the last trading session at $32.96, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $43.23 indicates a potential upside of 31.2%.The average comprises three short-term price targets ranging from a low of $42.00 to a high of $45.00, with a standard deviation of $1.57. While the lowest estimate indicat ...

Shares of Figure Technology (FIGR) have gained 0.2% over the past four weeks to close the last trading session at $37.29, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $49.11 indicates a potential upside of 31.7%.The mean estimate comprises nine short-term price targets with a standard deviation of $6.17. While the lowest estimate of $40.00 indicates a 7.3% increase from the c ...

Shares of VAREX IMAGING (VREX) have gained 3.2% over the past four weeks to close the last trading session at $11.8, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15.33 indicates a potential upside of 29.9%.The mean estimate comprises three short-term price targets with a standard deviation of $3.06. While the lowest estimate of $12.00 indicates a 1.7% increase from the curre ...

Daktronics (DAKT) closed the last trading session at $18.77, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $23.67 indicates a 26.1% upside potential.The average comprises three short-term price targets ranging from a low of $16.00 to a high of $31.00, with a standard deviation of $7.51. While the lowest estimate indicates a decline of 14.8% from the current price lev ...

Core Viewpoint - Compass Therapeutics, Inc. (CMPX) has shown a 13% gain over the past four weeks, with a mean price target of $12.62 indicating a potential upside of 134.1% from the current price of $5.39 [1] Price Targets and Analyst Estimates - The mean estimate consists of 13 short-term price targets with a standard deviation of $6.67, where the lowest estimate is $8.00 (48.4% increase) and the highest is $30.00 (456.6% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about CMPX's earnings prospects, with a positive trend in earnings estimate revisions correlating with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 1.6% over the past month, indicating a positive outlook [12] - CMPX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' price targets can often be overly optimistic due to business incentives [3][8] - While price targets should not be ignored, they should be approached with skepticism, as they may not accurately predict stock price movements [10]

Braze, Inc. (BRZE) closed the last trading session at $34.93, gaining 23.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $46.63 indicates a 33.5% upside potential.The average comprises 19 short-term price targets ranging from a low of $38.00 to a high of $68.00, with a standard deviation of $6.53. While the lowest estimate indicates an increase of 8.8% from the current price lev ...

Core Viewpoint - nCino (NCNO) shows potential for significant upside, with a mean price target of $34.8 indicating a 34.3% increase from the current price of $25.92 [1] Price Targets and Analyst Estimates - The mean estimate consists of 15 short-term price targets with a standard deviation of $4.02, suggesting variability in analyst predictions [2] - The lowest estimate is $27.00, indicating a 4.2% increase, while the highest estimate is $41.00, suggesting a potential surge of 58.2% [2] - A low standard deviation indicates a high degree of agreement among analysts regarding price movement [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about nCino's earnings prospects, with a strong consensus on higher EPS estimates [11] - Over the last 30 days, five estimates have been revised upward, leading to a 55.1% increase in the Zacks Consensus Estimate [12] - nCino holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Targets - While consensus price targets may not be reliable indicators of the extent of potential gains, they can provide a directional guide for price movement [14]